Two New Drug Classes Tied to Better Survival in Type 2 Diabetes Two New Drug Classes Tied to Better Survival in Type 2 Diabetes

Based on a network meta-analysis, SGLT-2 inhibitors and GLP-1 agonists may be preferred over DPP-4 inhibitors as add-on therapies to metformin for type 2 diabetes, researchers report.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news